Skip to main content
. 2018 Nov 21;2018(11):CD006135. doi: 10.1002/14651858.CD006135.pub3

Rosenfeldt 2003.

Methods Six‐week randomised controlled cross‐over trial
Participants Fifty‐eight children 1 to 13 years of age with eczema diagnosed using the UK Working Party Criteria. Children who had received systemic corticosteroids at any time were excluded
Setting: hospital paediatric and dermatology departments in Denmark
15 participants lost to follow‐up
Interventions Skimmed milk powder with dextrose anhydrate 2 g/d or a mix of Lactobacillus rhamnosus 19070‐2 and Lactobacillus reuteri DSM12246 at 2 × 10¹º CFUs/d of each strain. Both placebo and probiotic preparations administered twice daily with 2.5 to 5 mL water
Outcomes • Global self‐assessment by participant or parent*
 • SCORAD*
 • Need for other treatment ‐ topical corticosteroid*
*Denotes outcomes prespecified for this review
Notes Study was supported by Danish Research and Development Programme for Food Technology
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Quote: "The patients were randomised in a double‐blind crossover design...." ‐ "Blocked randomisation with 4 patients in each block was applied"
Comment: inadequate information for a judgement on risk of bias
Allocation concealment (selection bias) Unclear risk No information provided. Inadequate information for a judgement
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Quote: "The patients were randomised in a double‐blind crossover design...."
Comment: inadequate information for a judgement on risk of bias
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Quote: "The patients were randomised in a double‐blind crossover design...."
Comment: inadequate information for a judgement on risk of bias
Incomplete outcome data (attrition bias) 
 All outcomes High risk Fifteen participants (25.9%) excluded from analysis. Five of these excluded during active treatment and 9 during placebo. Reasons for exclusion reported
Comment: high rates of exclusion probably affecting all outcomes
Selective reporting (reporting bias) Low risk No evidence of selective reporting
Other bias Low risk No other bias found